Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hetzer Medical Indonesia Tbk. (MEDS) vs Chandra Asri Pacific Tbk. (TPIA) Price & Performance

Hetzer Medical Indonesia Tbk.Trade
Chandra Asri Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Hetzer Medical Indonesia Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp82 (market cap 126.56B, 319.74M 24h volume), while Chandra Asri Pacific Tbk. trades at Rp1,930 (market cap 165.24T, 271.53M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 1305.6× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (319.74M versus 271.53M). Which is the better fit depends on your goals.

MEDSTPIA
Market Cap
126.56B165.24T
Volume
319.74M271.53M
Lot
3.2M2.72M
Turnover
27.4B522.13B
Average Price
85.681,922.9
Value
27.4B522.13B
Indicative Equilibrium Price
821,930
Indicative Equilibrium Volume
12.79K69.58K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MEDS
View details
TPIA
View details

About Hetzer Medical Indonesia Tbk.

PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.

Read more on MEDS

About Chandra Asri Pacific Tbk.

PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.

Read more on TPIA